Cargando…
Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease
SIMPLE SUMMARY: The development of brain metastases, or intracranial metastatic disease (IMD), is a serious and life-altering complication for many patients with cancer. While there have been substantial advancements in the treatments available for IMD and in our understanding of its pathogenesis, c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656478/ https://www.ncbi.nlm.nih.gov/pubmed/34885083 http://dx.doi.org/10.3390/cancers13235973 |